Clinical Trials currently opened for recruitment:

START Study

Randomised study to determine whether immediate initiation of ART is superior to deferral of ART until the CD4+ declines below 350 in patients who are ARV naive with a CD4+ above 500.

Gilead Booster Trial

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults